Monograph Details
|
|
Pain & Pyrexia
> Narcotic analgesics
|
|
TALWIN-NX |
| Manufacturer |
|
Sanofi Aventis |
| Legal Classification |
|
CIV |
| Pharmacological Class |
|
Opioid (agonist-antagonist) + narcotic antagonist. |
| Generic Name |
|
Pentazocine (as HCl) 50mg, naloxone HCl 0.5mg; scored tabs. |
| Indications |
|
Moderate to severe pain. |
| Children |
|
Not recommended. |
| Adults |
|
1 tab every 3–4 hrs; max 12 daily. |
| Precautions |
|
Head injury. Increased intracranial pressure. Biliary tract surgery. Convulsive disorders. Impaired respiratory, renal, or hepatic function. MI. Drug abusers. Labor and delivery. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Potentiation with alcohol, CNS depressants. May precipitate withdrawal in narcotic addicts. |
| Adverse Reactions |
|
Sedation, respiratory depression, hallucinations, disorientation, nausea, vomiting, constipation, seizures, rash, blood dyscrasias; urinary retention (rare). |
| How Supplied |
|
Tabs—100 |
|
|
|
|